Nanoparticle-Based Drug Delivery

Nanoparticle-based drug delivery explores the design and application of nanoscale materials to enhance the efficacy and safety of therapeutic agents. Research in this area focuses on developing novel nanoparticle formulations, such as liposomes, polymeric nanoparticles, and inorganic nanoparticles, for targeted delivery of drugs, genes, and imaging agents. Investigations examine how nanoparticle size, shape, surface chemistry, and composition influence drug loading, release kinetics, cellular uptake, and biodistribution. This work aims to overcome biological barriers, reduce off-target toxicity, and improve treatment outcomes for a range of diseases.

Arkansas's agricultural and biomedical sectors provide unique contexts for this research. For instance, developing targeted delivery systems for pesticides or veterinary medicines aligns with the state's significant agricultural industry. Furthermore, addressing public health challenges, such as cancer and infectious diseases, which disproportionately affect certain demographic groups within Arkansas, benefits from advancements in precise and effective drug delivery. Understanding the toxicological implications of nanomaterials is also crucial for both environmental and human health.

This field draws upon expertise in materials science, chemistry, biology, pharmacology, and medicine. Researchers across multiple Arkansas institutions collaborate to advance understanding and application, engaging with areas including cancer treatment, imaging technologies, and toxicological studies.